Recombinant CTLA4 (Quavonlimab Biosimilar) antibody

Catalog No. ABIN7676064

The Human Monoclonal anti-CTLA4 (Quavonlimab Biosimilar) antibody is suitable to detect CTLA4 (Quavonlimab Biosimilar) in samples from Human. It has been validated for BLI, ELISA, FACS, Func and SPR.

Quick Overview for Recombinant CTLA4 (Quavonlimab Biosimilar) antibody (ABIN7676064)

Target: CTLA4 (Quavonlimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CTLA4 (Quavonlimab Biosimilar) antibody is un-conjugated

Application: Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-CTLA4 (Quavonlimab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-CTLA-4 / CD152 Reference Antibody (quavonlimab)

Characteristics: Anti-CTLA-4 / CD152 Reference Antibody (quavonlimab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for CTLA4 (Quavonlimab Biosimilar)

Target: CTLA4 (Quavonlimab Biosimilar)

Alternative Name: CTLA-4 (Quavonlimab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P16410